MedPath

E.R. Squibb & Sons, L.L.C.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

18

FDA:18

Drug Approvals

OPDIVO

Approval Date
Mar 6, 2024
FDA

OPDUALAG

Approval Date
Mar 1, 2024
FDA

BARACLUDE

Approval Date
Nov 24, 2023
FDA

Augtyro

Approval Date
Nov 15, 2023
FDA

REYATAZ

Approval Date
Nov 7, 2023
FDA

KENALOG-40

Approval Date
Oct 31, 2023
FDA

ORENCIA

Approval Date
Oct 30, 2023
FDA

KENALOG-10

Approval Date
Oct 27, 2023
FDA

EVOTAZ

Approval Date
May 12, 2023
FDA

AZACTAM

Approval Date
Mar 17, 2023
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy